OPK Research and Charts

OPK - OPKO Health Inc (Healthcare: Diagnostics & Research)

Projected Earnings Date: 2025-02-06 (Delayed quote data 2025-01-06)

Last 1.45	Change ⇓ -0.03 (-2.03%)	Volume 5,484,091
	Open 1.48	High 1.49	Low 1.45

8EMA (Daily) 1.48	40EMA (Daily) 1.53	50EMA (Daily) 1.53	STO (Daily) 12.424	MACD Hist (Daily) -0.021
8EMA (Weekly) 1.508	40EMA (Weekly) 1.46	50EMA (Weekly) 1.46	STO (Weekly) 35.385	MACD Hist (Weekly) -0.031


Company Profile
Opko Health is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a global supply-chain operation and holding company in Ireland. Opko also owns a specialty active pharmaceutical ingredients manufacturer in Israel. The company's bio-reference testing business consists of routine testing and esoteric testing. Routine tests measure various health parameters, such as the functions of the heart, kidney, liver, thyroid, and other organs.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.